Global Information
회사소개 | 문의 | 비교리스트

세계의 에피제네틱스 시장 - 제품별, 용도별, 지역별 : 시장 규모와 예측

Global Epigenetics Market, by Product, Application, Technology, by Region, Growth Potential, Trends Analysis, Competitive Market Size and Forecast, 2019-2025

리서치사 Blueweave Consulting & Research Private Limited
발행일 2019년 03월 상품 코드 833055
페이지 정보 영문 120 Pages
가격
US $ 4,450 ₩ 5,515,000 PDF (Single User Licence)
US $ 7,150 ₩ 8,861,000 PDF (Global Licence)


세계의 에피제네틱스 시장 - 제품별, 용도별, 지역별 : 시장 규모와 예측 Global Epigenetics Market, by Product, Application, Technology, by Region, Growth Potential, Trends Analysis, Competitive Market Size and Forecast, 2019-2025
발행일 : 2019년 03월 페이지 정보 : 영문 120 Pages

세계의 에피제네틱스(Epigenetics) 시장을 분석했으며, 시장의 기본 구조와 성장 촉진요인 및 억제요인, 시장 전체 및 용도별·기술별·지역별 동향 전망(과거 4년간, 향후 7년간), 시장 전략 경향과 사례, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 분석 프레임워크

제2장 분석 방법

제3장 주요 요약

제4장 산업 분석

  • 업계 밸류체인 분석
  • 업계에 대한 영향력과 성장 촉진요인
    • 성장 촉진요인
    • 업계의 과제
    • 시장 기회
  • 기술 환경
  • 규제 프레임워크
  • 기업별 시장 점유율 분석
  • 성장 가능성 분석
  • 전략 전망
  • Porter's Five Forces 분석
  • PESTEL 분석

제5장 세계의 에피제네틱스 시장 : 개요

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 종류별, 용도별, 기술별, 지역별

제6장 세계의 에피제네틱스 시장 : 제품 종류별

  • 종류별 주요 동향
  • 키트
    • 시장 규모 실적과 예측(금액 기준, 통산 11년간)
    • 시장 규모 실적과 예측 : 지역별(금액 기준, 통산 11년간)
  • 시약
  • 효소
  • 차세대 시퀀싱(NGS)
  • 질량분석계
  • 중합효소 연쇄반응(PCR)
  • 바이오인포매틱스(Bioinformatics)

제7장 세계의 에피제네틱스 시장 : 용도별

  • 용도별 주요 동향
  • 종양
  • 심장질환
  • 면역

제8장 세계의 에피제네틱스 시장 : 기술별

  • 기술별 주요 동향
  • DNA 메틸화
  • 히스톤 수식화(Histone Modification)

제9장 세계의 에피제네틱스 시장 : 지역별

  • 지역별 주요 동향
  • 북미 시장
    • 시장 규모 실적과 예측(금액 기준, 통산 11년간)
    • 시장 규모 실적과 예측 : 제품 종류별(금액 기준, 통산 11년간)
    • 시장 규모 실적과 예측 : 기술별(금액 기준, 통산 11년간)
    • 시장 규모 실적과 예측 : 용도별(금액 기준, 통산 11년간)
    • 시장 규모 실적과 예측 : 국가별(금액 기준, 통산 11년간)
  • 아시아 시장
  • 유럽 시장
  • 중동 및 아프리카 시장
  • 라틴아메리카 시장

제10장 기업 개요(기업 개요, 재무지표 매트릭스, 주요 제품 환경, 기업 임원, 주요 경쟁사, 연락처 정보, SWOT 분석, 기업 전략 전망)

  • Illumina
  • Diagenode
  • QIAGEN
  • Merck Millipore
  • Abcam
  • Active Motif
  • New England Biolabs
  • Agilent
  • Zymo Research
  • PerkinElmer
  • Bio-Rad Roche Diagnostics
  • Thermo Fisher Scientific, Inc.,
  • Eisai Co., Ltd.
  • Novartis AG
LSH 19.05.22

Rapid advancements in gene technology and advantages of R&D in cost-effective & efficient for less labor intensive will boost Epigenetics market in the upcoming year. Moreover, the major factor driving the market growth is the growing application of epidemics in non-oncology diseases, the rise in the number of research activities; and the augmentations in collaborations between the biotechnology, academic, and pharmaceutical organizations. Furthermore, the huge increment in cancer affected patients and the extensive requirement of medical equipment in developing countries is accelerating the growth of Epigenetics market.

Additionally, Epigenetics technology help in the fulfilment of clinical needs of patients and help in early diagnosis of cancer diseases will contribute to Epigenetics market growth during the forecast periods. Rise in geriatric population and growing awareness about early diagnosis are key driver aiding to the growth of Epigenetics Market. According to BlueWeave Consulting, The Global Epigenetics Market is expected to grow with a significant rate during the forecast period 2018-2025 owing to the increasing demand for epigenetics technology for curbing out cancer-related diseases.

Kit Product type of Epigenetics market is projected to be the leading segment of the overall market during the forecast period

On the basis of product type, the Epigenetics Market has been segmented into Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, and Bioinformatics. Kit segment dominates the global Epigenetics owing to its ready to use & flexibility features for detecting the cancer infected diseases. Reagent will be the fastest growing segment due to its application as primers, buffers, magnetic beads, antibodies, histones in epigenetics technology.

Oncology is projected to lead the industry for utilizing applications of the Epigenetics during the forecast period

On the basis of application, the global Epigenetics market has been segmented into Oncology, Cardiology, and Immunology. By application type, Oncology will lead the market owing to the rise in cancer infected diseases population coupled with advancements in cancer disease detecting devices. Cardiology is expected to grow at the fastest rate during the forecast period owing to the government's supports and huge R&D in the field of cancer-related diseases by pharmaceuticals companies.

DNA Methylation is expected to dominating technology for utilizing in Epigenetics segment during the forecast period

On the basis of Technology Type, the global Epigenetics market has been segmented into DNA Methylation, Histone Modification, and others. DNA Methylation is expected to dominate the market owing to the rise in cancer affected population coupled with its application to early detection of cancer diseases. Histone Modification market is expected to be the fastest growing market due to its huge usage in altering chromatin structure or recruiting histone modifiers.

Asia accounts for the lion's share of the global Epigenetics market during the anticipated period.

On the basis of region, the Epigenetics market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the global Epigenetics market over the forecast period owing to government encouragement through financial aid, rises in geriatric population and high awareness for technological advancements in genetic disease The Asia Pacific is estimated to witness the fastest growing market over the forecast period owing to augmentation in R&D infrastructure, encouragement by government initiatives, and diversified healthcare market.

Global Epigenetics Market Competitive Landscape

Companies, such as Illumina, Diagenode, QIAGEN, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, PerkinElmer, Bio-Rad Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., and Novartis AG are the key players in manufacturing of Epigenetics products.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of Global Epigenetics Market size & forecast. The report promises to provide state-of-the-art technology of Epigenetics production and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

Table of Contents

1. Research Frame work

  • 1.1. Research Objective
  • 1.2. Market Definition and Scope
  • 1.3. Market segmentation

2. Research methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Market Size Estimation
  • 2.6. Assumption for the Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Epigenetics Industry Insights

  • 4.1. Industry Value Chain analysis
  • 4.2. Industry impact and Forces
    • 4.2.1. Growth Drivers
    • 4.2.2. Industry Challenges
    • 4.2.3. opportunities
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company market share analysis,2018
  • 4.6. Growth potential analysis,2018
  • 4.7. Strategic Outlook
  • 4.8. Porter's analysis
  • 4.9. PESTEL analysis

5. Global Epigenetics Market Overview

  • 5.1. Market size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By Application
    • 5.2.3. By Technology
    • 5.2.4. By Region

6. Global Epigenetics Market, By Product Type

  • 6.1. Key Type Trends
  • 6.2. Kit
    • 6.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.3. Reagent
    • 6.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.4. Enzymes
    • 6.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.4.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.5. NGS
    • 6.5.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.5.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.6. Mass Spectrometer
    • 6.6.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.6.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.7. PCR
    • 6.7.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.7.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 6.8. Bioinformatics
    • 6.8.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 6.8.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

7. Global Epigenetics Market, By Applications

  • 7.1. Key market Trends
  • 7.2. Oncology
    • 7.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 7.3. Cardiology
    • 7.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 7.4. Immunology
    • 7.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 7.4.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

8. Global Epigenetics Market, By Technology

  • 8.1. Key market Trends
  • 8.2. DNA Methylation,
    • 8.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 8.2.2. Market estimates & forecast, by region, 2015-2025, (USD Million)
  • 8.3. Histone Modification
    • 8.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 8.3.2. Market estimates & forecast, by region, 2015-2025, (USD Million)

9. Global Epigenetics Market, By Region

  • 9.1. Key Regional Market trends
  • 9.2. North America
    • 9.2.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.2.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.2.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.2.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.2.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.3. Asia
    • 9.3.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.3.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.3.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.3.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.3.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.4. Europe
    • 9.4.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.4.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.4.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.4.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.4.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.5. Middle East & Africa
    • 9.5.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.5.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.5.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.5.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.5.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)
  • 9.6. Latin America
    • 9.6.1. Market estimates & forecast, 2015-2025, (USD Million)
    • 9.6.2. Market estimates & forecast by Product type, 2015-2025, (USD Million)
    • 9.6.3. Market estimates & forecast, by Technology , 2015-2025, (USD Million)
    • 9.6.4. Market estimates & forecast, by Applications, 2015-2025, (USD Million)
    • 9.6.5. Market estimates & forecast, by Country, 2015-2025, (USD Million)

10. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, SWOT Analysis and Strategic Outlook)

  • 10.1. Illumina
  • 10.2. Diagenode
  • 10.3. QIAGEN
  • 10.4. Merck Millipore
  • 10.5. Abcam
  • 10.6. Active Motif
  • 10.7. New England Biolabs
  • 10.8. Agilent
  • 10.9. Zymo Research
  • 10.10. PerkinElmer
  • 10.11. Bio-Rad Roche Diagnostics
  • 10.12. Thermo Fisher Scientific, Inc.,
  • 10.13. Eisai Co. Ltd.
  • 10.14. Novartis AG
Back to Top
전화 문의
F A Q